The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
Schizophrenia and the α7 Nicotinic Acetylcholine Receptor
Abstract
In addition to the devastating symptoms of psychosis, many people with schizophrenia also suffer from cognitive impairment. These cognitive symptoms lead to marked dysfunction and can impact employability, treatment adherence, and social skills. Deficits in P50 auditory gating are associated with attentional impairment and may contribute to cognitive symptoms and perceptual disturbances. This nicotinic cholinergic-mediated inhibitory process represents a potential new target for therapeutic intervention in schizophrenia. This chapter will review evidence implicating the nicotinic cholinergic, and specifically, the alpha7 nicotinic receptor system in the pathology of schizophrenia. Impaired auditory sensory gating has been linked to the alpha7 nicotinic receptor gene on the chromosome 15q14 locus. A majority of persons with schizophrenia are heavy smokers. Although nicotine can acutely reverse diminished auditory sensory gating in people with schizophrenia, this effect is lost on a chronic basis due to receptor desensitization. The alpha7 nicotinic agonist 3-(2,4 dimethoxy)benzylidene-anabaseine (DMXBA) can also enhance auditory sensory gating in animal models. DMXBA is well tolerated in humans and a new study in persons with schizophrenia has found that DMXBA enhances both P50 auditory gating and cognition. alpha7 Nicotinic acetylcholine receptor agonists appear to be viable candidates for the treatment of cognitive disturbances in schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Translational P50 research has repeatedly linked sensory gating to cholinergic modulation, particularly α7 nicotinic acetylcholine receptor mechanisms, and to local inhibitory interneuron function within hippocampal and related cortical circuits [164,169,170,171].”
In the citing paper
“Other neurotransmitters (e.g., 40), which are also implicated in schizophrenia, also modulate visual processing.”
From Visual perception and its impairment in schizophrenia (2008) · cites this paper as [40]
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Smoking and Mental Illness: A Population-Based Prevalence Study
Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000) · JAMA · doi:10.1001/jama.284.20.2606 · Cited by 2,508
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141 · cited 2×
“Following the identification of genetic markers specific to the 7 nicotinic acetylcholine receptor gene (CHRNA-7) at 15q13–14 (Chini et al., 1994), P50 auditory gating was linked to the chromosome 15q14 locus of CHRNA-7 (Freedman et al., 1997).”
InfluentialSelf-citationPrevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 1×
“The Prototypic a7 Nicotinic Agonist, Nicotine, and Schizophrenia The frequency of tobacco smoking is elevated in people with schizophrenia in both inpatient (De Leon et al., 1995; Llerena et al., 2003) and outpatient settings (Diwan et al., 1998; Hughes et al., 1986).”
BackgroundCigarette smoking: implications for psychiatric illness
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.546 · Cited by 723
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678 · cited 1×
“Decreased 7 nicotinic receptor binding has been noted in the reticular nucleus of the thalamus (Court et al., 1999), the hippocampus (Freedman et al., 1995), and the cingulate cortex (Marutle et al., 2001).”
BackgroundSelf-citationNicotinic acetylcholine involvement in cognitive function in animals
Levin, E. D., & Simon, B. B. (1998) · Psychopharmacology · doi:10.1007/s002130050667 · Cited by 678
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 579
Research works printed but not linked: 1
- Kem, 1996, Two primary GTS‐21 metabolites are potent partial agonists at alpha‐7 nicotinic receptors expressed in the Xenopus oocyte, Soc. Neurosci. Abstr., 22, 268
Cited by
Functional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Abnormal neural oscillations and synchrony in schizophrenia
Uhlhaas, P. J., & Singer, W. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2774 · Cited by 2,120
Benowitz, N. L. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809890 · Cited by 1,508
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics
Benowitz, N. L. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094742 · Cited by 979
“Nicotine acting on α7 nAChRs may improve sensory gating, which is abnormal in schizophrenics (57).”
Background
Metadata
- Authors
- Martin, L. F., & Freedman, R.
- Affiliations
- Denver VA Medical Center (US)
- ORCID
- Freedman, Robert
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2007
- Volume
- 78
- Pages
- 225-246
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W97382084
- Cited by
- 213
- References
- 179
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 6 · 2022: 7 · 2021: 10 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 9 · 2016: 16 · 2015: 15 · 2014: 13 · 2013: 20 · 2012: 22
- FWCI
- 25.70
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- International review of neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, auditory gating, cognitive impairment, nicotine, receptor desensitization, nicotinic agonists, attentional impairment
- MeSH terms
- Acetylcholine, Animals, Brain, Cognition Disorders, Hallucinations, Humans, Receptors, Nicotinic, Schizophrenia, Nicotinic Agonists, Genetic Predisposition to Disease, Sensory Gating, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Schizophrenia and the α7 Nicotinic Acetylcholine Receptor. https://app.cochat.ai/papers/10.1016/s0074-7742(06)78008-4
- The paper
- Martin, L. F., & Freedman, R. (2007). Schizophrenia and the α7 Nicotinic Acetylcholine Receptor. International Review of Neurobiology. https://doi.org/10.1016/s0074-7742(06)78008-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.